These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 15858126

  • 1. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
    Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ.
    J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
    [Abstract] [Full Text] [Related]

  • 2. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ.
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [Abstract] [Full Text] [Related]

  • 3. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
    Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D.
    Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
    [Abstract] [Full Text] [Related]

  • 4. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B.
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
    Ishida K, Araki A, Kobayashi M, Taniyama K, Nabika T, Nagasaki M.
    Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
    [Abstract] [Full Text] [Related]

  • 6. Association of antibody to E2 protein of human papillomavirus and p16INK4A with progression of HPV-infected cervical lesions.
    Chuerduangphui J, Pientong C, Swangphon P, Luanratanakorn S, Sangkomkamhang U, Tungsiriwattana T, Kleebkaow P, Burassakarn A, Ekalaksananan T.
    Med Oncol; 2018 May 09; 35(6):93. PubMed ID: 29744680
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt M, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint W, Doorbar J.
    Am J Surg Pathol; 2015 Nov 09; 39(11):1518-1528. PubMed ID: 26379150
    [Abstract] [Full Text] [Related]

  • 9. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G, Marras V, Wenger JM, Santeufemia DA, Ambrosini G, Lutzoni R, Dessole M, Cherchi PL.
    Eur J Gynaecol Oncol; 2013 Nov 09; 34(3):227-30. PubMed ID: 23967551
    [Abstract] [Full Text] [Related]

  • 10. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 11. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL, Koh CC, Nazarina AR, Teoh KH, Looi LM.
    Malays J Pathol; 2016 Apr 25; 38(1):33-8. PubMed ID: 27126662
    [Abstract] [Full Text] [Related]

  • 12. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G, Yang B, Abdul-Karim FW.
    Int J Gynecol Pathol; 2015 Mar 25; 34(2):180-6. PubMed ID: 25675189
    [Abstract] [Full Text] [Related]

  • 13. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH.
    Am J Surg Pathol; 2017 May 25; 41(5):607-615. PubMed ID: 28403015
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.
    Ishikawa M, Fujii T, Saito M, Nindl I, Ono A, Kubushiro K, Tsukazaki K, Mukai M, Nozawa S.
    Int J Gynecol Cancer; 2006 May 25; 16(1):347-53. PubMed ID: 16445657
    [Abstract] [Full Text] [Related]

  • 17. Heat shock protein 27 and p16 immunohistochemistry in cervical intraepithelial neoplasia and squamous cell carcinoma.
    Tozawa-Ono A, Yoshida A, Yokomachi N, Handa R, Koizumi H, Kiguchi K, Ishizuka B, Suzuki N.
    Hum Cell; 2012 Mar 25; 25(1):24-8. PubMed ID: 22302674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear.
    Bose S, Evans H, Lantzy L, Scharre K, Youssef E.
    Diagn Cytopathol; 2005 Jan 25; 32(1):21-4. PubMed ID: 15584047
    [Abstract] [Full Text] [Related]

  • 20. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar 25; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.